• 6623 Citations
  • 44 Scopus h-Index
20042020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2004 2019

2019

Accurate patient-specific machine learning models of glioblastoma invasion using transfer learning

Hu, L. S., Yoon, H., Eschbacher, J. M., Baxter, L. C., Dueck, A., Nespodzany, A., Smith, K. A., Nakaji, P., Xu, Y., Wang, L., Karis, J. P., Hawkins-Daarud, A. J., Singleton, K. W., Jackson, P. R., Anderies, B. J., Bendok, B., Zimmerman, R. S., Quarles, C., Porter-Umphrey, A. B., Mrugala, M. & 11 others, Sharma, A., Hoxworth, J. M., Sattur, M. G., Sanai, N., Koulemberis, P. E., Krishna, C., Mitchell, J. R., Wu, T., Tran, N., Swanson, K. & Li, J., Jan 1 2019, In : American Journal of Neuroradiology. 40, 3, p. 418-425 8 p.

Research output: Contribution to journalArticle

Open Access
Glioblastoma
Cell Count
Neoplasms
Image-Guided Biopsy
Diffusion Tensor Imaging
1 Citation (Scopus)

Analytical Methods for Observational Data to Generate Hypotheses and Inform Clinical Decisions

DeWees, T., Vargas, C. E., Golafshar, M. A., Harmsen, W. S. & Dueck, A., Jan 1 2019, In : Seminars in Radiation Oncology.

Research output: Contribution to journalArticle

Observational Studies
Randomized Controlled Trials
Research Personnel
Costs and Cost Analysis
Research
1 Citation (Scopus)

Brain MR radiomics to differentiate cognitive disorders

Alzheimer’s Disease Neuroimaging Initiative, Jul 1 2019, In : Journal of Neuropsychiatry and Clinical Neurosciences. 31, 3, p. 210-219 10 p.

Research output: Contribution to journalArticle

Magnetic Resonance Spectroscopy
Dementia
Alzheimer Disease
Brain
Discriminant Analysis
3 Citations (Scopus)

Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?

King, M. T., Dueck, A. & Revicki, D. A., May 1 2019, In : Medical Care. 57, p. S38-S45

Research output: Contribution to journalArticle

Decision Making
Patient Reported Outcome Measures
Qualitative Research
Calibration
Reference Values

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

Tamari, R., Rapaport, F., Zhang, N., McNamara, C., Kuykendall, A., Sallman, D. A., Komrokji, R., Arruda, A., Najfeld, V., Sandy, L., Medina, J., Litvin, R., Famulare, C. A., Patel, M. A., Maloy, M., Castro-Malaspina, H., Giralt, S. A., Weinberg, R. S., Mascarenhas, J. O., Mesa, R. & 6 others, Rondelli, D., Dueck, A., Levine, R. L., Gupta, V., Hoffman, R. & Rampal, R. K., Jun 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 6, p. 1142-1151 10 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Transplantation
Mutation
Hematopoietic Stem Cell Transplantation
Survival
3 Citations (Scopus)

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT premeeting toward consensus on core sets for randomized controlled trials

Andersen, K. M., Cheah, J. T. L., March, L., Bartlett, S. J., Beaton, D., Bingham, C. O., Brooks, P. M., Christensen, R., Conaghan, P. G., D’Agostino, M. A., De Wit, M., Dueck, A., Goodman, S. M., Grosskleg, S., Hill, C. L., Howell, M., Mackie, S. L., Richards, B., Shea, B., Singh, J. A. & 4 others, Strand, V., Tugwell, P., Wells, G. A. & Simon, L. S., Aug 1 2019, In : Journal of Rheumatology. 46, 8, p. 1053-1058 6 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Safety
Rheumatology
Therapeutics
Rheumatic Diseases

Online yoga in myeloproliferative neoplasm patients: Results of a randomized pilot trial to inform future research

Huberty, J., Eckert, R., Dueck, A., Kosiorek, H., Larkey, L., Gowin, K. & Mesa, R., Jun 7 2019, In : BMC Complementary and Alternative Medicine. 19, 1, 121.

Research output: Contribution to journalArticle

Open Access
Yoga
Neoplasms
Sleep
Anxiety
Tumor Necrosis Factor-alpha
2 Citations (Scopus)

Oral idasanutlin in patients with polycythemia vera

Mascarenhas, J., Lu, M., Kosiorek, H., Virtgaym, E., Xia, L., Sandy, L., Mesa, R., Petersen, B., Farnoud, N., Najfeld, V., Rampal, R., Dueck, A. & Hoffman, R., Aug 8 2019, In : Blood. 134, 6, p. 525-533 9 p.

Research output: Contribution to journalArticle

Polycythemia Vera
Essential Thrombocythemia
Interferons
Toxicity
Chemical activation
4 Citations (Scopus)

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Chung, A. E., Shoenbill, K., Mitchell, S. A., Dueck, A., Schrag, D., Bruner, D. W., Minasian, L. M., St Germain, D., O'Mara, A. M., Baumgartner, P., Rogak, L. J., Abernethy, A. P., Griffin, A. C. & Basch, E. M., Feb 20 2019, In : Journal of the American Medical Informatics Association. 26, 4, p. 276-285 10 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Terminology
Medical Dictionaries
Research
Neoplasms

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

Deshields, T. L., Dueck, A., Rogers, K., Brown, J. R., Shanafelt, T., Mintzer, D. & Byrd, J. C., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
Psychology
Neoplasms

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

Mascarenhas, J., Baer, M. R., Kessler, C., Hexner, E., Tremblay, D., Price, L., Sandy, L., Weinberg, R., Pahl, H., Silverman, L. R., Goldberg, J. D., Kosiorek, H., Dueck, A. & Hoffman, R., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Primary Myelofibrosis
lestaurtinib
10 Citations (Scopus)

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. & Letellier, C., Jan 22 2019, In : JAMA - Journal of the American Medical Association. 321, 3, p. 306-307 2 p.

Research output: Contribution to journalLetter

Lung Neoplasms
2018
3 Citations (Scopus)

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

Marcellino, B. K., Hoffman, R., Tripodi, J., Lu, M., Kosiorek, H., Mascarenhas, J., Rampal, R. K., Dueck, A. & Najfeld, V., Dec 26 2018, In : Blood advances. 2, 24, p. 3581-3589 9 p.

Research output: Contribution to journalArticle

Chromosome Aberrations
Neoplasms
Proteins
Polycythemia Vera
Essential Thrombocythemia
1 Citation (Scopus)

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

Barginear, M., Dueck, A., Allred, J. B., Bunnell, C., Cohen, H. J., Freedman, R. A., Hurria, A., Kimmick, G., Le-Rademacher, J., Lichtman, S., Muss, H. B., Shulman, L. N., Sitiki Copur, M., Biggs, D., Ramaswamy, B., Lafky, J. M. & Jatoi, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Paclitaxel
Leukemia
Breast Neoplasms
Neoplasms
Terminology

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cyclophosphamide
Dexamethasone
Safety
Peripheral Nervous System Diseases
13 Citations (Scopus)

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

Thanarajasingam, G., Minasian, L. M., Baron, F., Cavalli, F., De Claro, R. A., Dueck, A., El-Galaly, T. C., Everest, N., Geissler, J., Gisselbrecht, C., Gribben, J., Horowitz, M., Ivy, S. P., Jacobson, C. A., Keating, A., Kluetz, P. G., Krauss, A., Kwong, Y. L., Little, R. F., Mahon, F. X. & 20 others, Matasar, M. J., Mateos, M. V., McCullough, K., Miller, R. S., Mohty, M., Moreau, P., Morton, L. M., Nagai, S., Rule, S., Sloan, J. A., Sonneveld, P., Thompson, C. A., Tzogani, K., van Leeuwen, F. E., Velikova, G., Villa, D., Wingard, J. R., Wintrich, S., Seymour, J. F. & Habermann, T. M., Jan 1 2018, (Accepted/In press) In : The Lancet Haematology.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Neoplasms
Needs Assessment
Stem Cell Transplantation
B-Cell Lymphoma
2 Citations (Scopus)

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

Basch, E. M., Scholz, M., de Bono, J. S., Vogelzang, N., de Souza, P., Marx, G., Vaishampayan, U., George, S., Schwarz, J. K., Antonarakis, E. S., O'Sullivan, J. M., Kalebasty, A. R., Chi, K. N., Dreicer, R., Hutson, T. E., Dueck, A., Bennett, A. V., Dayan, E., Mangeshkar, M., Holland, J. & 2 others, Weitzman, A. L. & Scher, H. I., Jan 1 2018, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Mitoxantrone
Castration
Prednisone
Prostatic Neoplasms
Pain
5 Citations (Scopus)

Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse events in a multicenter trial: NCCTG N1048

Basch, E., Dueck, A., Rogak, L. J., Mitchell, S. A., Minasian, L. M., Denicoff, A. M., Wind, J. K., Shaw, M. C., Heon, N., Shi, Q. D., Ginos, B., Nelson, G. D., Meyers, J. P., Chang, G. J., Mamon, H. J., Weiser, M. R., Kolevska, T., Reeve, B. B., Bruner, D. W. & Schrag, D., Nov 1 2018, In : Journal of Clinical Oncology. 36, 31, p. 3120-3125 6 p.

Research output: Contribution to journalArticle

Terminology
Multicenter Studies
Compliance
National Cancer Institute (U.S.)
Self Report

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, S., Sperinde, J., Liu, H., Gligorov, J., Spano, J. P., Antoine, M., Moreno Aspitia, A., Tan, W., Winslow, J., Petropoulos, C. J., Chenna, A., Bates, M., Weidler, J. M., Huang, W., Dueck, A. & Perez, E. A., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3053-3058 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Breast Neoplasms
Research Design
Therapeutics
Biomarkers

Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies

Mazza, G. L., Kunze, K. L., Langlais, B. T., Kosiorek, H. E., DeWees, T., Geyer, H. L., Scherber, R. M., Mesa, R. A. & Dueck, A., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Symptom Assessment
Neoplasms
Internet
Fatigue
Research Design

Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study

Mikhael, J. R., Manola, J., Dueck, A., Hayman, S., Oettel, K., Kanate, A. S., Lonial, S. & Rajkumar, S. V., Sep 1 2018, In : Blood Cancer Journal. 8, 9, 86.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Kidney
Renal Insufficiency
Dialysis

Microsatellitosis in Patients with Melanoma

with the Sentinel Lymph Node Working Group, Jan 1 2018, (Accepted/In press) In : Annals of Surgical Oncology.

Research output: Contribution to journalArticle

Melanoma
Survival
Confidence Intervals
SEER Program
Sentinel Lymph Node Biopsy
3 Citations (Scopus)

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

Bottomley, A., Pe, M., Sloan, J. A., Basch, E., Bonnetain, F., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Dueck, A., Devlin, N., Flechtner, H. H., Gotay, C., Greimel, E., Griebsch, I., Groenvold, M., Hamel, J. F., King, M., Kluetz, P. G. & 20 others, Koller, M., Malone, D. C., Martinelli, F., Mitchell, S. A., Moinpour, C. M., Musoro, J. Z., O’Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Pimentel, F. L., Quinten, C., Reijneveld, J. C., Schürmann, C., Smith, A. W., Soltys, K. M., Sridhara, R., Taphoorn, M. J. B., Velikova, G. & Coens, C., Jan 1 2018, (Accepted/In press) In : Clinical Trials.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Quality of Life
Neoplasms
Guidelines
Research

Neuropsychological comparison of incident MCI and prevalent MCI

Hansen, A., Caselli, R. J., Schlosser-Covell, G., Golafshar, M. A., Dueck, A., Woodruff, B. K., Stonnington, C. M., Geda, Y. E. & Locke, D. E., Jan 1 2018, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 10, p. 599-603 5 p.

Research output: Contribution to journalArticle

Cognitive Dysfunction
Research Subjects
Memory Disorders
Alzheimer Disease
Research

Patient Perspectives Regarding Allogeneic Bone Marrow Transplantation in Myelofibrosis

Palmer, J., Scherber, R., Girardo, M., Geyer, H., Kosiorek, H., Dueck, A., Jain, T. & Mesa, R., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Homologous Transplantation
Hematopoietic Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
3 Citations (Scopus)
Terminology
Industry
Clinical Trials
Therapeutics
National Cancer Institute (U.S.)
8 Citations (Scopus)

Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment

Caselli, R. J., Langlais, B. T., Dueck, A., Henslin, B. R., Johnson, T. A., Woodruff, B. K., Hoffman-Snyder, C. & Locke, D. E., Apr 1 2018, In : Journal of the American Geriatrics Society. 66, 4, p. 671-678 8 p.

Research output: Contribution to journalArticle

Health Transition
Personality
Confidence Intervals
Alzheimer Disease
Personality Tests

Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?

Langlais, B. T., Geyer, H., Scherber, R., Mesa, R. A. & Dueck, A., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Quality of Life
Neoplasms
Fatigue
Health Transition
Personality
Cognitive Dysfunction
4 Citations (Scopus)

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study

Gupta, V., Kosiorek, H. E., Mead, A., Klisovic, R. B., Galvin, J. P., Berenzon, D., Yacoub, A., Viswabandya, A., Mesa, R. A., Goldberg, J., Price, L., Salama, M. E., Weinberg, R. S., Rampal, R., Farnoud, N., Dueck, A., Mascarenhas, J. O. & Hoffman, R., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Myeloproliferative Disorders
Primary Myelofibrosis
Cell Transplantation
Arm
Unrelated Donors
3 Citations (Scopus)

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Rampal, R. K., Mascarenhas, J. O., Kosiorek, H. E., Price, L., Berenzon, D., Hexner, E., Abboud, C. N., Kremyanskaya, M., Weinberg, R. S., Salama, M. E., Menghrajani, K., Najfeld, V., Sandy, L., Heaney, M. L., Levine, R. L., Mesa, R. A., Dueck, A., Goldberg, J. D. & Hoffman, R., Dec 26 2018, In : Blood advances. 2, 24, p. 3572-3580 9 p.

Research output: Contribution to journalArticle

decitabine
Blast Crisis
Safety
Neoplasms
Essential Thrombocythemia
2 Citations (Scopus)

Software for administering the national cancer institute⇔s patient-reported outcomes version of the common terminology criteria for adverse events: Usability study

Schoen, M. W., Basch, E., Hudson, L. L., Chung, A. E., Mendoza, T. R., Mitchell, S. A., Germain, D. S., Baumgartner, P., Sit, L., Rogak, L. J., Shouery, M., Shalley, E., Reeve, B. B., Fawzy, M. R., Bhavsar, N. A., Cleeland, C., Schrag, D., Dueck, A. & Abernethy, A. P., Jul 1 2018, In : Journal of Medical Internet Research. 20, 7, e10070.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Terminology
Software
Telephone
Clinical Trials
15 Citations (Scopus)

Sorafenib for advanced and refractory desmoid tumors

Gounder, M. M., Mahoney, M. R., Van Tine, B. A., Ravi, V., Attia, S., Deshpande, H. A., Gupta, A. A., Milhem, M. M., Conry, R. M., Movva, S., Pishvaian, M. J., Riedel, R. F., Sabagh, T., Tap, W. D., Horvat, N., Basch, E., Schwartz, L. H., Maki, R. G., Agaram, N. P., Lefkowitz, R. A. & 5 others, Mazaheri, Y., Yamashita, R., Wright, J. J., Dueck, A. & Schwartz, G. K., Dec 20 2018, In : New England Journal of Medicine. 379, 25, p. 2417-2428 12 p.

Research output: Contribution to journalArticle

Aggressive Fibromatosis
Placebos
Confidence Intervals
Neoplasms
Disease-Free Survival
3 Citations (Scopus)

Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review

Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL), Sep 1 2018, In : The Lancet Oncology. 19, 9, p. e459-e469

Research output: Contribution to journalReview article

Randomized Controlled Trials
Breast Neoplasms
Quality of Life
Patient Reported Outcome Measures
PubMed
7 Citations (Scopus)

Stratifying SLN incidence in intermediate thickness melanoma patients

Chang, J. M., Kosiorek, H. E., Dueck, A., Leong, S. P. L., Vetto, J. T., White, R. L., Avisar, E., Sondak, V. K., Messina, J. L., Zager, J. S., Garberoglio, C., Kashani-Sabet, M. & Pockaj, B. A., Jan 1 2018, (Accepted/In press) In : American Journal of Surgery.

Research output: Contribution to journalArticle

Sentinel Lymph Node Biopsy
Melanoma
Incidence
Upper Extremity
Lower Extremity

Subjective cognitive impairment and the broad autism phenotype

Caselli, R. J., Langlais, B. T., Dueck, A., Locke, D. E. & Woodruff, B. K., Jan 1 2018, In : Alzheimer Disease and Associated Disorders. 32, 4, p. 284-290 7 p.

Research output: Contribution to journalArticle

Autistic Disorder
Phenotype
Symptom Assessment
Cognitive Dysfunction
Personality

Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study

Jain, T., Kosiorek, H. E., Kung, S. T., Shah, V. S., Dueck, A., Gonzalez-Calle, V., Luft, S., Reeder, C. B., Adams, R., Noel, P., Larsen, J. T., Mikhael, J. R., Bergsagel, P. L., Stewart, A. K. & Fonseca, R., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Amyloidosis
Retrospective Studies
Light
Therapeutics
5 Citations (Scopus)

What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales

Atkinson, T. M., Hay, J. L., Dueck, A., Mitchell, S. A., Mendoza, T. R., Rogak, L. J., Minasian, L. M. & Basch, E., Jan 1 2018, (Accepted/In press) In : Journal of Pain and Symptom Management.

Research output: Contribution to journalArticle

Neoplasms
2017
4 Citations (Scopus)

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
Lymphoma
B-Cell Lymphoma
13 Citations (Scopus)

A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy–Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012

Fogh, S. E., Deshmukh, S., Berk, L. B., Dueck, A., Roof, K., Yacoub, S., Gergel, T., Stephans, K., Rimner, A., DeNittis, A., Pablo, J., Rineer, J., Williams, T. M. & Bruner, D., Mar 15 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 4, p. 786-796 11 p.

Research output: Contribution to journalArticle

Honey
Esophagitis
lungs
Lung Neoplasms
pain
23 Citations (Scopus)

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

Ertz-Archambault, N., Kosiorek, H., Taylor, G. E., Kelemen, K., Dueck, A., Castro, J., Marino, R., Gauthier, S., Finn, L., Sproat, L., Palmer, J., Mesa, R. A., Al-Kali, A., Foran, J. M. & Tibes, R., Jul 1 2017, In : JAMA oncology. 3, 7, p. 936-943 8 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Autoimmune Diseases
Odds Ratio
Azathioprine
11 Citations (Scopus)

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: An analysis by the MPN QOL international working group

Geyer, H. L., Kosiorek, H., Dueck, A., Scherber, R., Slot, S., Zweegman, S., te Boekhorst, P. A. W., Senyak, Z., Schouten, H. C., Sackmann, F., Fuentes, A. K., Hernández-Maraver, D., Pahl, H. L., Griesshammer, M., Stegelmann, F., Döhner, K., Lehmann, T., Bonatz, K., Reiter, A., Boyer, F. & 32 others, Etienne, G., Ianotto, J. C., Ranta, D., Roy, L., Cahn, J. Y., Harrison, C. N., Radia, D., Muxi, P., Maldonado, N., Besses, C., Cervantes, F., Johansson, P. L., Barbui, T., Barosi, G., Vannucchi, A. M., Paoli, C., Passamonti, F., Andreasson, B., Ferrari, M. L., Rambaldi, A., Samuelsson, J., Cannon, K., Birgegard, G., Xiao, Z., Xu, Z., Zhang, Y., Sun, X., Xu, J., Kiladjian, J. J., Zhang, P., Gale, R. P. & Mesa, R. A., 2017, In : Haematologica. 102, 1, p. 85-93 9 p.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Polycythemia Vera
Neoplasms
Primary Myelofibrosis
Fatigue

A statistician's perspective on a long time to publish

Dueck, A., Jan 1 2017, In : The Lancet Haematology. 4, 1, p. e12

Research output: Contribution to journalComment/debate

7 Citations (Scopus)

Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype

Desai, A. J., Dong, M., Langlais, B. T., Dueck, A. & Miller, L. J., Aug 1 2017, In : American Journal of Clinical Nutrition. 106, 2, p. 447-456 10 p.

Research output: Contribution to journalArticle

Cholecystokinin
Phenotype
Population
Obesity
Cholesterol
9 Citations (Scopus)

Determination of mild, moderate, and severe pain interference in patients with cancer

Shi, Q., Mendoza, T. R., Dueck, A., Ma, H., Zhang, J., Qian, Y., Bhowmik, D. & Cleeland, C. S., Jun 1 2017, In : Pain. 158, 6, p. 1108-1112 5 p.

Research output: Contribution to journalArticle

Pain
Neoplasms
Equipment and Supplies
Symptom Assessment
Pain Measurement
1 Citation (Scopus)

Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials

Gwaltney, C., Paty, J., Kwitkowski, V. E., Mesa, R. A., Dueck, A., Papadopoulos, E. J., Wang, L., Feliciano, J. & Coons, S. J., Aug 1 2017, In : Leukemia Research. 59, p. 26-31 6 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Clinical Trials
Symptom Assessment
Patient Reported Outcome Measures
Surveys and Questionnaires
8 Citations (Scopus)

Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE

Mendoza, T. R., Dueck, A., Bennett, A. V., Mitchell, S. A., Reeve, B. B., Atkinson, T. M., Li, Y., Castro, K. M., Denicoff, A., Rogak, L. J., Piekarz, R. L., Cleeland, C. S., Sloan, J. A., Schrag, D. & Basch, E., Jun 1 2017, In : Clinical Trials. 14, 3, p. 255-263 9 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Terminology
Self Report
Nausea
Libraries
21 Citations (Scopus)

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Basch, E., Dueck, A., Rogak, L. J., Minasian, L. M., Kelly, W. K., O'Mara, A. M., Denicoff, A. M., Seisler, D., Atherton, P. J., Paskett, E., Carey, L., Dickler, M., Heist, R. S., Himelstein, A., Rugo, H. S., Sikov, W. M., Socinski, M. A., Venook, A. P., Weckstein, D. J., Lake, D. E. & 5 others, Biggs, D. D., Freedman, R. A., Kuzma, C., Kirshner, J. J. & Schrag, D., Aug 1 2017, In : JAMA oncology. 3, 8, p. 1043-1050 8 p.

Research output: Contribution to journalArticle

Clinical Trials
Neoplasms
Research Personnel
Self Report
Multicenter Studies
21 Citations (Scopus)

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

Basch, E., Pugh, S. L., Dueck, A., Mitchell, S. A., Berk, L., Fogh, S., Rogak, L. J., Gatewood, M., Reeve, B. B., Mendoza, T. R., O'Mara, A. M., Denicoff, A. M., Minasian, L. M., Bennett, A. V., Setser, A., Schrag, D., Roof, K., Moore, J. K., Gergel, T., Stephans, K. & 3 others, Rimner, A., DeNittis, A. & Bruner, D. W., Jun 1 2017, In : International Journal of Radiation Oncology Biology Physics. 98, 2, p. 409-418 10 p.

Research output: Contribution to journalArticle

terminology
Chemoradiotherapy
Terminology
Multicenter Studies
Clinical Trials